Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors

Clinical and Experimental Immunology

Volumn 130, Issue 3, 2002, Pages 509-517

  Papagno, Laura ^a   Appay, V ^a   Sutton, J ^a   Rostron, T ^a   Gillespie, G M A ^a   Ogg, G S ^a   King, A ^a   Makadzange, A T ^a   Waters, A ^b   Balotta, C ^c   Vyakarnam, A ^b   Easterbrook, P J ^b   Rowland Jones, S L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Cytotoxic T lymphocytes; HIV 1; Long term non progressor; T cell help; T cell maturation

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON;

ARTICLE; ASSAY; CELL ACTIVITY; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOMEGALOVIRUS; CYTOTOXICITY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PHENOTYPE; PRIORITY JOURNAL; STAINING; T LYMPHOCYTE;

ADULT; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; DISEASE PROGRESSION; EPITOPES; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 18744362995     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.02005.x     Document Type: Article

References (37)

1. McMichael AJ, O'Callaghan CA. A new look at T cells. J Exp Med 1998; 187:1367-71.
2. Pantaleo G, Menzo S, Vaccarezza M et al. Studies in subjects with long-term non-progressive human immunodeficiency virus infection. N Engl J Med 1995; 332:209-16.
3. Lieberman J, Shankar P, Manjunath N et al. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 2001; 98:1667-77.
4. Zajac AJ, Blattman JN, Murali-Krishna K et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998; 188:2205-13.
5. Wahren B, Morfeldt-Mansson L, Biberfeld G et al. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol 1987; 61:2017-23.
6. + T helper cell depletion occurs. J Clin Invest 1988; 82:1908-14.
7. +cell numbers and clinical staging. J Clin Invest 1989; 84:1892-9.
8. + T cell responses associated with control of viremia [see comments]. Science 1997; 278:1447-50.
9. Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses [comment]. J Exp Med 1998; 188:2199-204.
10. Appay V, Nixon DF, Donahoe SM et al. HIV-specific CD8 (+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192:63-75.
11. Easterbrook PJ, Schrager LK. Long-term non-progression in HIV infection, methodological issues and scientific priorities. Report of an international European Community National Institutes of Health Workshop, The Royal Society, London, England, November 27-29, 1995. Scientific Coordinating Committee. AIDS Res Hum Retroviruses 1998; 14:1211-28.
12. + lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:496-505.
13. Bunce M, O'Neill CM, Barnardo MC et al. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46:355-67.
14. Korber B, Brander C, Haynes B et al. HIV Molecular Immunology Database. Los Alamos: Theoretical Biology and Biophysics (T10), 1999.
15. + memory T cells. J Exp Med 1997; 186:859-65.
16. Altman JD, Moss PAH, Goulder PJR et al. Phenotypic analysis of antigen-specific T lymphocytes [published erratum appears in Science 1998; 280 (5371): 1821]. Science 1996; 274:94-6.
17. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression [see comments]. Nat Med 1999; 5:518-25.
18. Kaslow RA, Carrington M, Apple R et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996; 2:405-11.
19. Klein MR, van der Burg SH, Hovenkamp E et al. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. J Gen Virol 1998; 79:2191-201.
20. Migueles SA, Sabbaghian MS, Shupert WL et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term non-progressors. Proc Natl Acad Sci USA 2000; 97:2709-14.
21. + T cells specific for EBV in healthy virus carriers. J Immunol 1999; 162:1827-35.
22. Goulder PJ, Tang Y, Brander C et al. Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med 2000; 192:1819-32.
23. Gillespie GM, Wills MR, Appay V et al. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8 (+) T lymphocytes in healthy seropositive donors. J Virol 2000; 74:8140-50.
24. Price DA, Goulder PJ, Klenerman P et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 1997; 94:1890-5.
25. Oxenius A, Gunthard HF, Hirschel B et al. Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8 (+) T lymphocyte activation in response to therapeutic manipulation of virus load. Eur J Immunol 2001; 31:1115-21.
26. + T cells. J Exp Med 1997; 186:1407-18.
27. + CD28(-) cytotoxic effector clones. Int Immunol 1999; 11:229-41.
28. Appay V, Papagno L, Spina CA et al. Dynamics of T cell responses in HIV infection. J Immunol 2002; 168:3660-6.
29. Appay V, Hansasuta P, Sutton J et al. Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. Aids 2002; 16:161-70.
30. Harrer E, Harrer T, Barbosa P et al. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term non-progressor. J Infect Dis 1996; 173:476-9.
31. Brander C, Hartman KE, Trocha AK et al. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J Clin Invest 1998; 101:2559-66.
32. Betts MR, Ambrozak DR, Douek DC et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4 (+) and CD8 (+) T cell responses: Relationship to viral load in untreated HIV infection. J Virol 2001; 75:11983-91.
33. Migueles SA, Connors M. Frequency and function of HIV-specific CD8 (+) T cells. Immunol Lett 2001; 79:141-50.
34. + T cell proliferation and effector function in vivo. Immunity 2000; 13:291-301.
35. Cao Y, Qin L, Zhang L et al. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995; 332:201-8.
36. Dalod M, Dupuis M, Deschemin JC et al. Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8 (+) responses in HIV type 1-infected patients: Comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J Virol 1999; 73:7108-16.
37. + T cells in HIV-infected progressors and long-term non-progressors. J Immunol 2000; 165:1082-92.